Evotec buys custom cells and reagents supplier

01/4/2013 | Genetic Engineering & Biotechnology News

Cell Culture Service, a supplier of custom cells and cell-based reagents, has been acquired by Evotec for $1.5 million upfront plus as much as $1.4 million in milestone fees. Evotec said the deal would improve its ability to offer integrated drug discovery and early development services for drugmakers. "CCS' experience and technologies for large-scale cell production are a perfect fit with Evotec's screening and in vitro pharmacology activities," Evotec COO Mario Polywka said.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY